Next Article in Journal
In Memoriam: Professor Marco Mumenthaler
Previous Article in Journal
Suspicious Veins
 
 
Clinical and Translational Neuroscience is published by MDPI from Volume 5 Issue 2 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with SAGE.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Project Report

Swiss Institute for Translational and Entrepreneurial Medicine (Sitem-Insel)

Sitem-Insel AG, Freiburgstrasse 18, 3010 Bern, Switzerland
Clin. Transl. Neurosci. 2017, 1(1), 4; https://doi.org/10.1177/2514183x17714101
Submission received: 29 December 2016 / Accepted: 22 March 2017 / Published: 20 September 2017

Abstract

Sitem-insel – the Swiss Institute for Translational and Entrepreneurial Medicine in Bern – was created to establish, operate and develop a National Center of Excellence for Translational Medicine. sitem-insel is organized as a non-profit oriented public private partnership. Translational medicine is a new, process-oriented discipline that aims to translate new findings and products emerging from private-sector development and basic research into clinical application. The discipline seeks to professionalize the essential interaction between scientists conducting basic research in the private sector and universities, clinicians, regulatory bodies and investors. The mission of sitem-insel is to create and foster an enhanced environment for translational medicine in Switzerland. The sitem-insel strategy rests on three pillars: (1) The sitem-insel School offers university-level continuing professional development courses taught by university and private-sector lecturers. (2) The sitem-insel Enabling Facilities provide infrastructure to foster cooperation between industrial partners, basic scientists and clinicians on the campus of the University Hospital of Bern (Inselspital) with the ultimate goal to bring novel diagnostic and therapeutic products towards clinical application. (3) The sitem-insel Promoting Services aim to optimize the administrative-regulatory effort along the route from laboratory bench to commercial products.
Keywords: translational medicine; entrepreneurship; inselspital; regulatory affairs; medtech translational medicine; entrepreneurship; inselspital; regulatory affairs; medtech

Share and Cite

MDPI and ACS Style

Frey, F.J. Swiss Institute for Translational and Entrepreneurial Medicine (Sitem-Insel). Clin. Transl. Neurosci. 2017, 1, 4. https://doi.org/10.1177/2514183x17714101

AMA Style

Frey FJ. Swiss Institute for Translational and Entrepreneurial Medicine (Sitem-Insel). Clinical and Translational Neuroscience. 2017; 1(1):4. https://doi.org/10.1177/2514183x17714101

Chicago/Turabian Style

Frey, Felix J. 2017. "Swiss Institute for Translational and Entrepreneurial Medicine (Sitem-Insel)" Clinical and Translational Neuroscience 1, no. 1: 4. https://doi.org/10.1177/2514183x17714101

APA Style

Frey, F. J. (2017). Swiss Institute for Translational and Entrepreneurial Medicine (Sitem-Insel). Clinical and Translational Neuroscience, 1(1), 4. https://doi.org/10.1177/2514183x17714101

Article Metrics

Back to TopTop